logo-loader
viewBenchmark Holdings PLC

Benchmark team discuss £43mln raise and commercial development of CleanTreat

Benchmark Holdings PLC's (LON:BMK) Peter George and Septima Maguire discuss with Proactive's Andrew Scott some of the detail around their planned £43mln fundraise which is being carried out by way of a share placing and open offer.

The raise is being done to fund the commercial development of its CleanTreat system.

It's a proprietary system that removes medicinal residues from treatment water and which is integral to the commercial delivery of product candidate BMK08, the company's novel sea lice treatment for sea lice.

Quick facts: Benchmark Holdings PLC

Price: 40 GBX

AIM:BMK
Market: AIM
Market Cap: £267.06 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Benchmark Holdings PLC named herein, including the promotion by the Company of Benchmark Holdings PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Benchmark Holdings' Peter George says sale of its vaccine facility is a...

Benchmark Holdings PLC's (LON:BMK) chairman Peter George speaks to Proactive London's Andrew Scott soon after agreeing to sell its vaccine manufacturing assets at its facility in Braintree, UK to Cell and Gene Therapy Catapult. George says he's pleased that Benchmark has been able to be part of...

1 week, 4 days ago

2 min read